English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/128002
COMPARTIR / IMPACTO:
Estadísticas
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Título

Respiratory infection by Corynebacterium striatum: Epidemiological and clinical determinants

AutorRenom, Feliu; Gomila, Margarita; Garau, Margarita; Gallegos, Maria del Carmen; Guerrero, Dolores; Lalucat, Jorge ; Soriano, Joan B.
Palabras claveepidemiology
respiratory infection
multidrug-resistance
genotype
Corynebacterium striatum
Advanced chronic obstructive pulmonary disease
Fecha de publicación27-jun-2014
EditorJohn Wiley & Sons
CitaciónNew Microbes and New Infections 2(4): 106-114 (2014)
Resumen© 2014 The Authors. The increasing prevalence of advanced chronic respiratory disease, with frequent exposure to broad-spectrum antibiotics for repeated and prolonged hospitalizations, favours the emergence of nosocomial respiratory infection by Gram-positive bacteria, such as outbreaks of Corynebacterium striatum. There is little evidence about patterns of respiratory infection, transmission and adaptive ability of this pathogen. Seventy-two C. striatum isolates from 51 advanced respiratory patients, mainly chronic obstructive pulmonary disease, were studied during 38 months. Patients were 74.8 ± 8.6 years old and 81.9% were men, who had required an average of 2.2 hospitalizations and 63.5 days in the hospital in the previous year. Of 49 isolates from 42 patients we were able to identify 12 clones by multilocus sequence analysis (MLSA), nine phenotypic variants and 22 antibiotic susceptibility patterns, and we determined their clinical and epidemiological determinants. MLSA allows identification of the existence of nosocomial outbreaks by transmission of the same or different clones, the persistence of the same clone in the environment or in patient airways for months. The study showed the high variability and adaptive capacity of the isolates, the antibiotic multidrug-resistance in all of them, and their contribution to a high morbidity and mortality (41%) during the study period.
Versión del editorhttp://dx.doi.org/10.1002/nmi2.48
URIhttp://hdl.handle.net/10261/128002
DOI10.1002/nmi2.48
Identificadoresdoi: 10.1002/nmi2.48
issn: 2052-2975
Aparece en las colecciones: (IMEDEA) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Renom-New_Microbes_and_New_Infections-2014-v2-p106.pdf1,18 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 

Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.